Raras
Buscar doenças, sintomas, genes...
Condrossarcoma
ORPHA:55880CID-10 · C49.9CID-11 · 2B50OMIM 215300DOENÇA RARA

Neoplasia mesenquimal maligna produtora de matriz cartilaginosa que surge do osso e dos tecidos moles. Geralmente afeta adultos de meia-idade a idosos. Os ossos pélvicos, costelas, cintura escapular e ossos longos são os locais mais comuns de envolvimento. A maioria dos condrossarcomas surge de novo, mas alguns podem se desenvolver em uma lesão cartilaginosa benigna preexistente.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Neoplasia mesenquimal maligna produtora de matriz cartilaginosa que surge do osso e dos tecidos moles. Geralmente afeta adultos de meia-idade a idosos. Os ossos pélvicos, costelas, cintura escapular e ossos longos são os locais mais comuns de envolvimento. A maioria dos condrossarcomas surge de novo, mas alguns podem se desenvolver em uma lesão cartilaginosa benigna preexistente.

Pesquisas ativas
32 ensaios
130 total registrados no ClinicalTrials.gov
Publicações científicas
9.210 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C49.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

Condrossarcoma
Início na idade adulta
HP:0001442
3sintomas
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 3 características clínicas mais associadas, ordenadas por frequência.

CondrossarcomaChondrosarcoma
Início na idade adultaAdult onset
HP:0001442

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico9.210PubMed
Últimos 10 anos200publicações
Pico2025107 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Not applicable, Unknown.

EXT1Exostosin-1Candidate gene tested inAltamente restrito
FUNÇÃO

Glycosyltransferase forming with EXT2 the heterodimeric heparan sulfate polymerase which catalyzes the elongation of the heparan sulfate glycan backbone (PubMed:10639137, PubMed:22660413, PubMed:36402845, PubMed:36593275, PubMed:9620772). Glycan backbone extension consists in the alternating transfer of (1->4)-beta-D-GlcA and (1->4)-alpha-D-GlcNAc residues from their respective UDP-sugar donors. Both EXT1 and EXT2 are required for the full activity of the polymerase since EXT1 bears the N-acetyl

LOCALIZAÇÃO

Golgi apparatus membraneGolgi apparatus, cis-Golgi network membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
HS-GAG biosynthesisDefective EXT2 causes exostoses 2
MECANISMO DE DOENÇA

Hereditary multiple exostoses 1

EXT is a genetically heterogeneous bone disorder caused by genes segregating on human chromosomes 8, 11, and 19 and designated EXT1, EXT2 and EXT3 respectively. EXT is a dominantly inherited skeletal disorder primarily affecting endochondral bone during growth. The disease is characterized by formation of numerous cartilage-capped, benign bone tumors (osteocartilaginous exostoses or osteochondromas) that are often accompanied by skeletal deformities and short stature. In a small percentage of cases exostoses have exhibited malignant transformation resulting in an osteosarcoma or chondrosarcoma. Osteochondromas development can also occur as a sporadic event.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
72.2 TPM
Fibroblastos
49.8 TPM
Artéria tibial
39.0 TPM
Artéria coronária
34.6 TPM
Pulmão
23.8 TPM
OUTRAS DOENÇAS (4)
chondrosarcomaexostoses, multiple, type 1trichorhinophalangeal syndrome type IIhereditary multiple osteochondromas
HGNC:3512UniProt:Q16394

Variantes genéticas (ClinVar)

642 variantes patogênicas registradas no ClinVar.

🧬 EXT1: NM_000127.3(EXT1):c.840G>T (p.Arg280Ser) ()
🧬 EXT1: NM_000127.3(EXT1):c.1383T>G (p.Tyr461Ter) ()
🧬 EXT1: NM_000127.3(EXT1):c.1065C>G (p.Cys355Trp) ()
🧬 EXT1: NM_000127.3(EXT1):c.1319del (p.Arg440fs) ()
🧬 EXT1: NM_000127.3(EXT1):c.448C>T (p.Gln150Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 129 variantes classificadas pelo ClinVar.

19
110
Patogênica (14.7%)
VUS (85.3%)
VARIANTES MAIS SIGNIFICATIVAS
EXT1: NM_000127.3(EXT1):c.599G>A (p.Trp200Ter) [Pathogenic]
EXT1: NM_000127.3(EXT1):c.1031C>T (p.Ser344Phe) [Likely pathogenic]
EXT1: NM_000127.3(EXT1):c.650_653delinsTTTG (p.Ala217_Lys218delinsValTer) [Likely pathogenic]
NR4A3: NM_006981.4(NR4A3):c.1712G>A (p.Ser571Asn) [Uncertain significance]
EXT1: NM_000127.3(EXT1):c.46T>A (p.Cys16Ser) [Uncertain significance]

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 27
1Fase 12
·Pré-clínico9
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Condrossarcoma

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

16 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

130 ensaios clínicos encontrados, 32 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
3.449 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 3.449

#1

Maxillary mesenchymal chondrosarcoma harboring HEY1::NCOA2 fusion in a 13-year-old girl: a rare case report and literature review.

Frontiers in pediatrics2026

Mesenchymal chondrosarcoma (MCS) is a rare and highly aggressive subtype of chondrosarcoma, accounting for less than 1% of all chondrosarcomas. It predominantly affects adolescents and young adults and frequently arises in craniofacial bones and soft tissues. Diagnosis is challenging because of significant histological overlap with other high-grade spindle cell sarcomas, particularly when the cartilaginous component is minimal or absent. The identification of the HEY1::NCOA2 gene fusion has emerged as a highly specific molecular marker for MCS, substantially improving diagnostic accuracy and providing potential therapeutic implications. We report the case of a 13-year-old girl who presented with a 3-month history of progressive right cheek swelling. Imaging revealed a destructive mass in the right maxillary sinus. Histopathological evaluation demonstrated a high-grade spindle cell tumor, initially interpreted as fibrosarcoma, showing diffuse vimentin positivity, a high Ki-67 proliferation index (35%-40%), and CD34 negativity. Comprehensive molecular analysis confirmed a pathogenic HEY1::NCOA2 gene fusion, while ETV6::NTRK3 fusion was excluded. The patient was treated with VAC chemotherapy (vincristine, actinomycin D, cyclophosphamide), local radiotherapy (60 Gy), cranial prophylactic radiotherapy (12 Gy), and subsequent debulking surgery. Follow-up 18F-FDG PET/CT demonstrated a partial metabolic response. Given persistent disease and molecular evidence suggesting activation of the PI3K/AKT/mTOR pathway in MCS, maintenance therapy with the mTOR inhibitor sirolimus was initiated. This case highlights the pivotal role of molecular diagnostics-particularly RNA sequencing-in establishing the diagnosis of mesenchymal chondrosarcoma and differentiating it from other high-grade pediatric sarcomas with overlapping morphology. Identification of the HEY1::NCOA2 fusion not only confirms the diagnosis but may also support biologically targeted therapeutic strategies. Multimodal treatment incorporating chemotherapy, radiotherapy, surgery, and targeted maintenance therapy can achieve meaningful disease control in aggressive craniofacial MCS. To our knowledge, this represents one of the very few reported pediatric cases of maxillary MCS with confirmed HEY1::NCOA2 fusion managed with sirolimus-based maintenance therapy.

#2

Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy.

Cells2026 Feb 24

Chondrosarcomas (ChSs) are mesenchymal chemo- and radiation-resistant tumors, representing the second most frequently diagnosed bone sarcoma after osteosarcoma and 20% of all bone sarcomas. Most of ChS patients have a good prognosis after complete surgical resection. Conversely, patients with inoperable disease, due to the tumor location or metastatic dissemination, represent a great clinical challenge due to the lack of effective therapeutic options. In this study, to the best of our knowledge, we document, for the first time in human ChS tissues, the existence of CD-31- and Podoplanin-negative vascular-like channels containing red blood cells, allowing us to hypothesize the occurrence of vasculogenic mimicry (VM) in ChSs. By using patient-derived ChS cells and a stabilized ChS cell line, we demonstrate that ChS cells are able to form in vitro tubules apparently similar to those formed by endothelial cells. Further characterization of these vessels revealed the pivotal role of the Urokinase Plasminogen Activator Receptor (uPAR) in mediating the capability of ChS cells to form VM. Finally, we provide evidence that, unlike bevacizumab, which did not exert any effect, the uPAR-derived antiangiogenic peptide RI-3 behaves as a potent inhibitor of VM.

#3

Endoscope-assisted Transmastoid Infralabyrinthine approach to the petrous apex: A new corridor for multicompartmental jugular foramen tumors.

Brain &amp; spine2026

Multicompartmental jugular foramen tumors may extend anteriorly and superiorly toward the petrous apex, posing significant challenges for traditional surgical corridors. The authors study the feasibility of endoscope-assisted transmastoid infralabyrinthine approach (e-TIA) to access the superior aspect of petrous apex. Five cadaveric specimens were studied. A reference object was placed transnasally at the petrous apex to assess surgical exposure. To assess the working space of e-TIA, cross-sectional area was measured using three-dimensional reconstruction. Furthermore, we reviewed three patients with multicompartmental jugular foramen tumor in which this corridor was used. The e-TIA, initiated with a 30° endoscope using the chopstick technique, accessed the superior petrous apex, Meckel's cave, and the internal carotid artery (ICA) from its cervical to lacerum segments. Radiological analysis demonstrated that the approach trajectory shifts at the cochlea level. Cross-sectional area analysis revealed that the e-TIA corridor provides sufficient space for manipulation of the endoscope, suction, and drill. Clinically, near total resection was achieved in all cases without new neurological complications. The e-TIA offers a systematic extension to the superior petrous apex and the ICA from its cervical to the lacerum segments. utilizing an angled endoscope to enhance visualization. When combined with an anterolateral approach, this dual-corridor strategy provides a unique "looking-up" line of sight to the petrous bone. Overall, the e-TIA represents a promising option in selected multicompartmental jugular foramen tumors with petrous apex extension.

#4

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

International journal of molecular sciences2026 Feb 20

Chondrosarcoma (ChS) is a rare bone malignancy with heterogeneous behavior, the molecular and immunological background of which remains unknown. No effective systemic treatment for advanced ChS patients is available. The aim of this study was to develop an immune-mutational classification of ChS and to search for novel prognostic factors and molecular targets. We performed an immunological-molecular profiling of 99 patients diagnosed with primary ChS G1-G3 and dedifferentiated ChS. An expression of 20 immune response markers was assessed by IHC and targeted the next-generation sequencing of 409 genes was performed. Immunological and mutational profiles were correlated with overall survival using a multivariate LASSO-penalized Cox model. Three immunophenotypes were described-"cold" (IMP1), "hot" (IMP2), and "intermediate" (IMP3). IMP1 was the most prevalent in G1 cases, while IMP2 was the most prevalent in dedifferentiated cases. IDH1/2 or TP53 mutations were associated with high-grade ChS (FDR < 0.05). IMP2 was characterized by a higher number of immune infiltrates in the central region of the tumor (HR: 3.3; CI: 1.13-9.8; p < 0.05). IDH1 mutations were present most often in IMP2 cases (HR: 3.8; CI: 1.75-8.1; p < 0.001). Tumor size, dedifferentiated subtype, IDH1 mutation and the presence of IMP2 were identified as independent negative prognostic survival factors in ChS. An immune-mutational classification system for ChS patients was proposed, which may be used to identify those potentially suited for immunotherapy combined with IDH-mutant inhibitors in future research.

#5

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Nature communications2026 Jan 29

Chondrosarcomas are rare cartilaginous neoplasms with limited treatment options. Isocitrate dehydrogenase 1/2 (mIDH1/2) mutations occur in 65% of chondrosarcomas. Here we report safety and efficacy of olutasidenib, an mIDH1 inhibitor, evaluated in patients with locally advanced or metastatic mIDH1 chondrosarcoma (Clinicaltrials.gov identifier: NCT03684811). The primary endpoint was objective response rate by tumor evaluation; secondary endpoints included adverse events, progression-free and overall survival. Patients received olutasidenib 150 mg twice daily. Twenty-three patients were enrolled; 16 were diagnosed with conventional chondrosarcoma (cCS). Median age was 57 (range, 30-71) years. In 21 response-evaluable patients, 11 (52%) had stable disease, 8 (38%) had progressive disease, and 2 (10%) were not evaluable. Median progression-free survival (mPFS) was 2.0 months (95% confidence interval [95%CI]: 1.7, 4.7); median overall survival was 16.0 months (95%CI: 7.7, not reached). Among patients with cCS, 10 (63%) had stable disease; 6 (38%) had progressive disease; mPFS was 3.5 months (95%CI: 1.7, 5.1). Median overall survival in cCS patients was 19.0 months (95% CI: 7.7, not reached). No dose-limiting toxicities were reported during the study. Olutasidenib was well tolerated and conferred disease control in cCS. Study limitations include open-label design and low patient sample due to rarity of cCS.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC5.036 artigos no totalmostrando 199

2026

Outcomes of oncovascular reconstruction in patients with extremity sarcomas.

JVS-vascular insights
2026

A multicorridor strategy including the infralabyrinthine route for extensive skull base chondrosarcoma: illustrative case.

Journal of neurosurgery. Case lessons
2026

Maxillary mesenchymal chondrosarcoma harboring HEY1::NCOA2 fusion in a 13-year-old girl: a rare case report and literature review.

Frontiers in pediatrics
2026

The spiral CT imaging characteristics of sarcomatous lesions in the maxillofacial bones: a retrospective analysis.

Journal of stomatology, oral and maxillofacial surgery
2026

Peritoneal Sarcomatosis Secondary to Conventional Chondrosarcoma: A Case Report.

Cureus
2026

Advances in Stereotactic Navigation for Primary Spine and Pelvis Tumor Resection and Reconstruction: A Systematic Review.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery
2026

Terminal presentation and postmortem diagnosis of a mesenchymal chondrosarcoma with extensive intracranial involvement.

Journal of neuropathology and experimental neurology
2026

Pediatric versus adult cases of primary osseous sarcomas of the spine: A population-based analysis.

North American Spine Society journal
2026

Wait, scan and then? Exploring the long-term natural course of 119 low-grade central cartilaginous lesions of the long bones with MRI follow-up.

European radiology
2026

Analysis of CCN6 in the Context of Human Health and Disease: Current Insights and Unexplored Frontiers.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy.

Cells
2026

Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature.

Journal of clinical medicine
2026

Guided Limited Maxillectomy and Staged Septal-Palatal Reconstruction for Low-Grade Chondrosarcoma of the Hard Palate: A Case Report and Literature Review.

Journal of clinical medicine
2026

Chopsticks mononostril approach with sphenoid sinus cranialization and septal mucosa suturing: a new minimally invasive concept and closure technique for endoscopic endonasal approaches.

Journal of neurosurgery
2026

Hearing Outcomes in the Surgical Management of Petroclival Malignancies: Understanding the Impact of Surgical Strategy and Adjuvant Radiotherapy.

Operative neurosurgery (Hagerstown, Md.)
2026

Advances in Radiation Therapy for Primary Bone Malignancies.

Technology in cancer research &amp; treatment
2026

Ruptured Uterine Leiomyosarcoma With Heterologous Components Including Osteosarcoma and Chondrosarcoma.

Journal of medical cases
2026

IDH enzyme inhibition in cancer therapy: mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma.

3 Biotech
2026

Regional and distant metastases from laryngeal chondrosarcoma: a systematic review.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
2026

Mandibular chondrosarcoma grade 2: a case report highlighting disease aggressiveness.

International journal of surgery case reports
2026

Individual and Community-Level Social Determinant Associations with Skull Base Chordoma and Chondrosarcoma Disparities in the United States.

Journal of neurological surgery. Part B, Skull base
2026

Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study.

Acta oncologica (Stockholm, Sweden)
2026

Endoscope-assisted Transmastoid Infralabyrinthine approach to the petrous apex: A new corridor for multicompartmental jugular foramen tumors.

Brain &amp; spine
2026

Endovascular Thrombectomy in a Patient with Acute Ischemic Stroke due to Tumor Emboli Associated with Cardiac Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.

NMC case report journal
2026

Autoimmune and malignant diseases secondary to autoimmune/inflammatory syndrome induced by modeling substances (ASIA-MS): A short communication of a clinical case series.

Reumatologia clinica
2026

Outcome of type 4 pelvic resection and reconstruction with a high hip center in malignant pelvic tumours: A case series and short-term review.

Journal of orthopaedic surgery (Hong Kong)
2026

Chondromyxoid Fibroma: An Updated Review.

In vivo (Athens, Greece)
2026

A series of extraskeletal myxoid chondrosarcomas with rare morphological and molecular variations.

Histopathology
2026

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

International journal of molecular sciences
2026

First Report of Primary Mesenchymal Chondrosarcoma of the Urinary Bladder.

International journal of surgical pathology
2026

Utilizing bulk and single-cell RNA sequencing to identify potential biomarkers linked to angiogenesis and integrated stress response in chondrosarcoma.

Scientific reports
2026

Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15.

Cancer immunology research
2026

Case of hereditary multiple exostoses with concomitant intrathoracic rib chondrosarcoma causing diaphragmatic haematoma in a teenage female.

Thorax
2026

Reconstruction after unplanned excisions of soft tissue sarcomas using intraoperative extracorporeal autogenous irradiated bone and tendon grafts: a report of three cases.

World journal of surgical oncology
2026

Laryngeal Chondrosarcoma: A SEER Database Analysis.

The Laryngoscope
2026

Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review).

Oncology reports
2026

A Dangerous Region Generation Method for Computer-Assisted Pelvic Bone Tumor Resection Surgery: A Retrospective Study.

Journal of clinical medicine
2026

A Systematic Review of Cutaneous Involvement in Metastatic Bone Sarcomas: Insights from 102 Reported Cases.

Cancers
2026

Pneumonectomy for an endobronchial carcinosarcoma with long-term survival: a case report.

AME case reports
2026

Development and verification of a competing risk model for forecasting cancer-specific survival in malignant bone tumor patients: an analysis of SEER database.

Translational cancer research
2026

Osteoarthritis and chondrosarcoma: Bioinformatics analysis based on single-cell RNA sequencing and molecular docking.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2026

Inframeatal intradural retrosigmoid petrosectomy (IIRP): Multicenter experience and anatomical review of an effective approach to the petroclival region.

Neurocirugia
2026

Excision of proximal fibular aggressive and malignant tumors: a new classification for surgical guidance.

Annals of joint
2026

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network.

ESMO open
2026

[Clinicopathological and molecular characteristics of extraskeletal myxoid chondrosarcoma: an analysis of sixteen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2026

The emerging role of mixed reality and artificial intelligence in sarcoma care: A systematic review.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2026

A Case Report of a Patient Presenting With Extra-skeletal Myxoid Chondrosarcoma.

Cureus
2026

Chondrosarcoma arising from long-standing Dysplasia Epiphysealis Hemimelica of the proximal humerus: A case report.

SICOT-J
2026

The anti-apoptotic protein lifeguard is expressed in osteosarcoma, chondrosarcoma and soft tissue sarcoma.

Oncology
2026

Impact of surgical margins and radiation therapy on survival in spinal chordoma and chondrosarcoma: a single-institution retrospective cohort study.

Journal of neurosurgery. Spine
2026

Atypical presentation and association of medullary thyroid carcinoma: reports from a tertiary care center in Northwest India.

Endocrinology, diabetes &amp; metabolism case reports
2026

An In Vitro Investigation of 5-Aminolevulinic Acid Mediated Photodynamic Therapy in Bone Sarcoma.

Oncology research
2026

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Nature communications
2026

A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma.

Cancer reports (Hoboken, N.J.)
2026

Ten Years of Atypical Cartilaginous Tumors-Is Curettage Really Enough?

Journal of clinical medicine
2026

Molecular and Immune Mechanisms Governing Cancer Metastasis, Including Dormancy, Microenvironmental Niches, and Tumor-Specific Programs.

International journal of molecular sciences
2026

"Radiological Grading" for Preoperative Assessment of Central Cartilaginous Tumors.

Cancers
2026

[A case of subglottic laryngeal chondrosarcoma].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
2026

A Needle in a Haystack: The Precision of Liquid Biopsy in Finding Bone Tumors.

Anti-cancer agents in medicinal chemistry
2026

Laryngeal Chondrosarcoma: Rare Malignancy of the Laryngeal Cartilages.

Mayo Clinic proceedings
2026

Transarterial Embolisation as Palliative Therapy for Oral Tumours in Canine and Feline Patients: A Retrospective Case Series.

Veterinary and comparative oncology
2026

Real-World Implementation of Next-Generation Sequencing in Sarcoma: Molecular Insights and Therapeutic Outcomes.

Medical sciences (Basel, Switzerland)
2025

Vomeric Chondrosarcoma: A Case Report of a Rare Entity With CT and MRI Findings.

Cureus
2026

Diagnosis of an intraluminal aortic chondrosarcoma via transarterial biopsy and treatment with stereotactic body radiation therapy in a dog.

The Journal of small animal practice
2026

Impact of proton vs. photon radiotherapy on overall survival in the management of spinal chondrosarcoma and mortality risk prediction: A nationwide analysis.

Neuro-oncology advances
2025

Avoiding Preemptive Extracorporeal Membrane Oxygenation in Near-Occlusive Tracheal Chondrosarcoma: An Awake Airway Strategy.

Cureus
2025

Clear Cell Myoepithelial Carcinoma of the Clavicle: A Case Report.

Cureus
2025

A retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature.

Nagoya journal of medical science
2025

Heart of the Matter: Echocardiogram Leading to the Discovery of Metastatic Pelvic Chondrosarcoma.

CASE (Philadelphia, Pa.)
2026

Accessible cartilage tumor malignancy prediction via vision-language foundation model adaptation.

Skeletal radiology
2026

<p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>.

Oncology reports
2026

Surgical Management of Chondrosarcoma of the T11 With The Aid of a 3D Printed Model: A Case Report With Review of Literature.

Indian journal of orthopaedics
2026

H3-3A gene mutation analysis in giant cell tumor of bone and its histologic mimics: A single institutional study from India.

Annals of diagnostic pathology
2026

Expanded Endoscopic Endonasal Transpterygoid Transclival Approach With Interdural Pituitary Hemitransposition for a Heavily Calcified Skull Base Chondrosarcoma With Adherence to the Internal Carotid Artery: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)
2026

Insights From the AO Spine Knowledge Forum Tumor Registries: Advancing the Understanding and Management of Primary Spine Tumors Through International Multicentric Collaboration. A Narrative Review.

Global spine journal
2025

Delayed Sacral Insufficiency Fracture Following Oncologic Resection of a Chondrosarcoma: Emphasizing the Role of Biomechanical Risk Assessment.

Journal of orthopaedic case reports
2026

[Biological reconstruction of the proximal humerus following resection of a conventional chondrosarcoma].

Orthopadie (Heidelberg, Germany)
2026

Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review.

The British journal of radiology
2026

CT and MR imaging features of periosteal chondrosarcoma.

Diagnostic and interventional imaging
2026

Single-stage functional lateral hemilaryngocricoidectomy for a locally advanced chondrosarcoma invading the hemicricoid.

BMJ case reports
2026

In Vivo Evaluation of a Self-Excitatory Near-Infrared ImmunoSCIFI Probe.

Bioconjugate chemistry
2026

Primary intracranial extraskeletal myxoid chondrosarcoma in a teenager with unusual frontal location and surgical complications: A case report and literature review.

Oncology letters
2025

Construction of nomograms for survival prediction in high-grade chondrosarcoma based on multivariable analysis: A SEER database study.

Journal of cancer research and therapeutics
2025

Thyroid Cartilage Hemangioma: Presentation, Imaging, Pathology, and Approach to Resection and Reconstruction.

The Annals of otology, rhinology, and laryngology
2026

Pathological fractures as an adverse prognostic factor in chondrosarcoma: Results of a systematic review, meta-analysis and institutional case series.

Journal of bone oncology
2025

Malignant Transformation of Musculoskeletal Lesions with Imaging-Pathology Correlation-Part 1: Bone Lesions.

Diagnostics (Basel, Switzerland)
2026

DISTAL (Distal tibia tumors treated with amputation versus limb Salvage): A systematic review and meta-analysis of oncologic, functional, and complication outcomes in malignant bone tumors.

Journal of orthopaedics
2026

Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study.

British journal of cancer
2025

Investigating the association between koala retrovirus and primary bone neoplasia in koalas (Phascolarctos cinereus) using real-time PCR and a novel immunohistochemistry assay.

Veterinary pathology
2025

Malignancy Ratio in Pediatric Patients with Hereditary Multiple Exostoses: True Association or Reporting Bias?

Pediatric reports
2025

Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at 3 Tesla.

Journal of functional biomaterials
2025

A Rare Case of Mandibular Chondrosarcoma Arising from Fibrous Dysplasia.

Dentistry journal
2025

Use of epidural anaesthesia as analgesic management in an asiatic lion (Panthera leo persica).

Veterinary research communications
2025

Tumor cells seeding in biopsy tracts after open biopsy in three patients with chondrosarcoma-Case reports.

Wiener klinische Wochenschrift
2025

The risk of pathological fractures after intralesional curettage in Atypical Cartilaginous Tumours: A retrospective cohort study.

Journal of bone oncology
2025

Primary mucinous sarcoma of the lung with EWSR1 translocation: a case report.

Frontiers in medicine
2025

Primary pulmonary chondrosarcoma: clinical case and review of the literature.

Therapeutic advances in respiratory disease
2025

Chondrosarcoma organoids reveal SHH pathway activation driven by PTCH1 and BCOR alterations.

Scientific reports
2025

Sinonasal teratocarcinosarcoma: a case report of a 41-year-old female.

American journal of translational research
2025

Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26.

Neuro-oncology
2025

Hydatic Cyst Infection of the Tibia Mimicking Chondrosarcoma on 18F-FDG PET/CT Scan.

Molecular imaging and radionuclide therapy
2025

Association of Cartilage Cap Thickness With Tumor Grade and Outcomes in Secondary Chondrosarcoma.

The Journal of the American Academy of Orthopaedic Surgeons
2026

Chondrosarcoma: Clinical behavior, molecular mechanisms, and emerging therapeutic strategies.

Critical reviews in oncology/hematology
2026

Evolution of a Surgical Technique: A Brief Communication Regarding 5 Cases of Three-Dimensional Printed Sternums.

Interdisciplinary cardiovascular and thoracic surgery
2025

Maintaining lung volume in a chest wall deformity after chest wall reconstruction.

Journal of thoracic disease
2025

Predictors of 30-day readmission and prolonged length of hospital stay after spinal chondrosarcoma resection: insights from the National Cancer Database.

Journal of neurosurgical sciences
2025

Can endothelial cell dysfunction decide surgical wound health in bone sarcoma? Prospective study evaluating factors predicting wound complications in sarcoma.

Journal of clinical orthopaedics and trauma
2025

Musculoskeletal Diseases: Mechanisms and Therapeutic Advances.

MedComm
2026

Epidemiology of Surgically Treated Foot and Ankle Bone Tumors: A Systematic Review.

Foot &amp; ankle international
2025

Rare Presentation of a Giant Paraspinal Chondrosarcoma: Case Report and Review of Literature.

Asian journal of neurosurgery
2025

Estimation of thermal conductivity of cortical and cancellous bone, muscle, fat, and chondrosarcoma tumor phantoms by using the hot plate method: preliminary study.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2025

Enchondromatosis of Both Hands With Possible Skull Bone Involvement: An Extremely Rare Condition in Adults.

Cureus
2025

Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.

Case reports in oncology
2025

Spontaneous regression of metastatic disease after palliative debulking surgery for heavily pre-treated extraskeletal myxoid chondrosarcoma: A case report.

Rare tumors
2026

Gastrointestinal Dysautonomia After Immune Checkpoint Inhibitor Therapy: A Case Series and Systematic Review.

Neurogastroenterology and motility
2025

Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.

Virchows Archiv : an international journal of pathology
2025

Anesthesia Management in Sternal Resection for Chondrosarcoma: A Multidisciplinary Successful Approach with Thoracic Epidural and Parasternal Block for Acute and Long-Term Pain Control.

Journal of clinical medicine
2025

Quality of Life and Clinical Outcomes in Patients with Skull Base Chordoma and Chondrosarcoma Treated with Pencil-Beam Scanning Proton Therapy.

Cancers
2025

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma.

Genome biology
2025

Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma.

Current oncology (Toronto, Ont.)
2025

Reduced 5-hydroxymethylcytosine due to TET2 downregulation is associated with chondrosarcoma progression.

Scientific reports
2025

Periacetabular Resection for Bone Tumors: Is There Still a Role for Massive Allograft-prosthesis Composite Reconstructions?

Clinical orthopaedics and related research
2025

Enchondroma of Hands: A Surgical Dilemma and Our Experience.

Journal of orthopaedic case reports
2025

From 2D to 3D: transforming malignant bone tumor research with advanced culture models.

Journal of Zhejiang University. Science. B
2026

Low grade chondrosarcoma of the hand treated with curettage: Long term outcomes.

Hand surgery &amp; rehabilitation
2025

Septal chondrosarcoma- An unusual cause of nasal obstruction.

Indian journal of cancer
2025

Alternative Splicing: A Critical Regulator in Human Bone Biology and Tumor Progression.

Research (Washington, D.C.)
2026

Survival outcomes and prognostic factors in temporal bone malignancies: A retrospective cohort of 20 patients.

Oncology letters
2026

Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants.

The American journal of surgical pathology
2025

Application of a rapid and accurate safe-margin volume generation method in computer-assisted bone tumor resection surgery.

Journal of orthopaedic surgery and research
2025

[Effectiveness evaluation of three-dimensional printed customized hemi-pelvic prosthesis for pelvic reconstruction after resection of massive pelvic tumor].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2025

Microsphere-Coated Drug Reservoirs in Titanium Implants with pH-Responsive and Osmolality-Adaptive Drug Release for Enhanced Antibacterial Efficacy and Biocompatibility.

ACS applied materials &amp; interfaces
2026

Central Skull Base Neoplasms.

Radiologic clinics of North America
2025

Glenohumeral Instability and Clinical Outcomes Following Proximal Humerus Resection and Megaprosthesis Implantation: A Systematic Review.

Journal of clinical medicine
2025

Megaprosthetic Reconstruction for Pathological Proximal Humerus Fractures: Infection Rates, Prevention Strategies, and Functional Outcomes-A Narrative Review.

Journal of clinical medicine
2025

Current Position of Nuclear Medicine Imaging in Primary Bone Tumors.

Diagnostics (Basel, Switzerland)
2025

Chondrosarcoma of the mandibular condyle.

BMJ case reports
2025

Transpterygoid Corridor for Upper Clival Chondrosarcoma: Understanding the Key Landmarks and Technical Nuances.

Neurology India
2025

Histone deacetylase in human sarcomas.

The International journal of biological markers
2025

G Protein-Coupled Receptor 35 Holds Potential as a Beacon of Hope for Treating Chondrosarcoma.

Balkan journal of medical genetics : BJMG
2025

The chordoid glioma PRKCA D463H mutation is a kinase inactive, gain-of-function allele that induces early-onset chondrosarcoma in mice.

Science signaling
2025

Misdiagnosis of Calcaneal Chondrosarcoma as Plantar Fasciitis: A Case Report.

Cureus
2025

Multidisciplinary approach for resection of an extremely large trunk chondrosarcoma: a case report.

Annals of medicine and surgery (2012)
2025

Preoperative Multi-model Images-based Radiomics Model for Distinguishing Spinal Osteosarcoma and Chondrosarcoma.

Current medical imaging
2025

Incidence and prognostic impact of regional lymph node metastasis at the time of diagnosis in soft-tissue sarcoma : a population-based cohort study.

The bone &amp; joint journal
2025

Patellar Involvement in Disseminated Rhinosporidiosis: A Case Report.

JBJS case connector
2026

Imaging findings and complications after curettage of atypical cartilaginous tumors in long bones: a retrospective single-center cohort study.

Skeletal radiology
2025

Expression and Clinical Significance of Cytochrome 1B1 in Bone Sarcomas.

Pharmaceuticals (Basel, Switzerland)
2025

Alternative Lengthening of Telomeres: A Prognostic Paradox in Cancer.

Cells
2025

Bimodality imaging as a companion to evaluate antitumour efficacy of TH-302 in experimental chondrosarcoma.

EJNMMI research
2025

Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control.

Advances in radiation oncology
2025

Proteasomal deubiquitinating enzyme USP14/UCHL5 inhibitor bAP15 suppresses endoplasmic reticulum stress-mediated apoptosis and tumor growth in human chondrosarcoma.

American journal of cancer research
2026

Is Ipsilateral Femoral Head Autograft Reconstruction Durable in Patients Undergoing Enneking II/II+III Tumor Resections at a Minimum 5-year Follow-up?

Clinical orthopaedics and related research
2025

Transformation and Management of Long-Bone Atypical Cartilaginous Tumours.

Cancers
2025

Monomelic, Multicentric, Metachronous Primary Chondrosarcoma of the Lower Limb: A Case Report.

Cureus
2025

Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy.

Frontiers in oncology
2026

Distinguishing Low-Grade Chondrosarcoma and Osteochondroma Using Visible-Near Infrared Hyperspectral Spectral Characteristics.

Journal of biophotonics
2026

Clinical and magnetic resonance imaging features of soft tissue extraskeletal myxoid chondrosarcoma: A retrospective observational cohort study.

Skeletal radiology
2025

Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas.

JCI insight
2025

Tracheal Chondrosarcoma: A Case Report and Discussion.

Case reports in oncology
2025

The prognostic potential of circulating biomarkers for sarcoma patients with pleural dissemination.

Pathology oncology research : POR
2025

From pathogenesis to the patient's bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma.

Journal of cancer research and clinical oncology
2025

In vitro characterization of OSA-424 and OSA-55: new canine models for osteosarcoma research.

The veterinary quarterly
2025

Proton beam radiation therapy vs. photon radiation therapy and the overall survival of adult and pediatric patients diagnosed with sarcoma.

Frontiers in oncology
2025

HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse model.

Translational oncology
2025

Core needle biopsy of periacetabular chondrosarcoma often results in undergrading but does not change management by experienced orthopaedic oncologists.

Scientific reports
2025

Mesenchymal chondrosarcoma of the Jaw: A case report and 25-Year review of the literature.

Oral oncology
2026

Sinonasal Sarcomas Management: An International Consensus Statement.

International forum of allergy &amp; rhinology
2025

The Resolution of a Biopsy-Proven Enchondroma in the Proximal Humerus Over a 14-Year Interval.

Cureus
2025

Conventional chondrosarcoma of the sternum presenting as a chest wall mass with multilobulated intra- and extra-thoracic extension.

Radiology case reports
2025

Resection of Primary Lesion for Patients With Metastatic Soft Tissue Sarcoma at Initial Presentation.

Anticancer research
2025

Epidemiological Analysis of Malignant Bone and Cartilage Tumors in the Hand With Focus on Chondrosarcoma: A Twenty-year Study with a Focus on Surgical Treatment Outcomes.

Anticancer research
2025

Soft tissue reconstruction of tumor-related proximal tibial hemiarthroplasty using synthetic mesh combined with a medial gastrocnemius flap.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology
2025

An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Time to treatment initiation in primary extremity sarcomas: Determinants and oncological outcomes in a tertiary LMIC cancer center.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Reconstruction of an extensive upper back defect following excision of chondrosarcoma using bilateral trapezius muscle and bilateral bipedicle fasciocutaneous flaps: A case report.

International journal of surgery case reports
2025

The benefits of combining an immunomodulator with a chemotherapy agent in chondrosarcoma-a proof of concept with mifamurtide.

Medical oncology (Northwood, London, England)
2025

BCOR-Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study.

Genes, chromosomes &amp; cancer
2025

Deep learning for automated segmentation of central cartilage tumors on MRI.

European radiology experimental
2025

A rare case report of uterine carcinosarcoma with bilateral ovarian Brenner tumors.

Frontiers in oncology
2025

Tumours of the ischiofemoral region: The largest case series.

Clinical imaging
2025

High-grade chondrosarcoma of the sacrum with mediastinal metastases and a tumor thrombus to the inferior vena cava and right atrium.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
2025

Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment.

Journal of immunotherapy and precision oncology
2025

Improving oncological outcomes for pelvic bone sarcomas: Is it possible?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Adenosarcoma of uterus characterized by differentiation of rhabdomyosarcoma and chondrosarcoma: A case report and review of literature.

Science progress
2025

Spontaneous oronasal ejection of neoplastic and non-neoplastic nodules by 21 dogs, 2000-2024.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2025

A Rare Osteoid Forming Carcinosarcoma Ex-Pleomorphic Adenoma of the Parotid Gland.

Case reports in pathology
2025

Computer vision based efficient segmentation and classification of multi brain tumor using computed tomography images.

Scientific reports
2025

Proton beam therapy for chondrosarcoma: A systematic narrative review and meta-analysis.

Critical reviews in oncology/hematology
2025

Grade 2 central chondrosarcoma treated by intralesional curettage: observation or surgery? : a multicentre retrospective study.

The bone &amp; joint journal
2025

The role of radiotherapy and chemotherapy in extraskeletal myxoid chondrosarcoma.

Journal of orthopaedic surgery and research
2025

Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial.

Med (New York, N.Y.)
2025

Enhancing YOLOv11 with Large Kernel Attention and Multi-Scale Fusion for Accurate Small and Multi-Lesion Bone Tumor Detection in Radiographs.

Diagnostics (Basel, Switzerland)
2025

Advances in the Molecular Biology of Chondrosarcoma for Drug Discovery and Precision Medicine.

Cancers
2025

Multi-Level Oncological Management of a Rare, Combined Mediastinal Tumor: A Case Report.

Current oncology (Toronto, Ont.)
2025

Long-term follow-up after cervical en bloc resection as salvage surgery of spinal chondrosarcoma: illustrative case.

Journal of neurosurgery. Case lessons
2025

Salvage Surgery with Iliac Wing Autograft Following Total Calcanectomy for Calcaneal Chondrosarcoma.

Journal of the American Podiatric Medical Association
2025

[Functional results after surgical treatment of long-lasting epidural compression of the neural structures in patients with spinal tumors].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2025

Dedifferentiated adamantinoma of long bones: a case report and literature review.

Frontiers in oncology
Ver todos os 5.036 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Condrossarcoma.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Condrossarcoma

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Maxillary mesenchymal chondrosarcoma harboring HEY1::NCOA2 fusion in a 13-year-old girl: a rare case report and literature review.
    Frontiers in pediatrics· 2026· PMID 41867924mais citado
  2. Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy.
    Cells· 2026· PMID 41827826mais citado
  3. Endoscope-assisted Transmastoid Infralabyrinthine approach to the petrous apex: A new corridor for multicompartmental jugular foramen tumors.
    Brain &amp; spine· 2026· PMID 41799388mais citado
  4. Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.
    International journal of molecular sciences· 2026· PMID 41752158mais citado
  5. Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
    Nature communications· 2026· PMID 41611702mais citado
  6. Chondroblastic Osteosarcoma of the Palate: A Rare Case Report with Diagnostic Considerations.
    J Dent (Shiraz)· 2026· PMID 41994059recente
  7. Rate and Type of Surgery and Prevalence of Malignancy in Patients With Ollier's Disease and Maffucci Syndrome.
    Am J Med Genet A· 2026· PMID 41992553recente
  8. Middle column trough technique to dissect the tumor away from the vessels for safe resection of anterior lumbar chondrosarcoma with major vascular involvement-A Technical Report.
    Eur Spine J· 2026· PMID 41991693recente
  9. AI-derived CT morphometric phenotypes predict survival, functional decline, and surgical morbidity following curative-intent surgical sarcoma resection.
    J Orthop Surg Res· 2026· PMID 41987222recente
  10. Osseous hydatidosis - A diagnostic mimic and a therapeutic challenge: Clinicopathological and radiological features of 21 cases from India.
    Indian J Pathol Microbiol· 2026· PMID 41987032recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:55880(Orphanet)
  2. OMIM OMIM:215300(OMIM)
  3. MONDO:0008977(MONDO)
  4. GARD:6055(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q1076087(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Condrossarcoma
Compêndio · Raras BR

Condrossarcoma

ORPHA:55880 · MONDO:0008977
Prevalência
1-9 / 100 000
Herança
Not applicable, Unknown
CID-10
C49.9 · Neoplasia maligna do tecido conjuntivo e tecidos moles, não especificados
CID-11
Ensaios
32 ativos
Início
Adult
Prevalência
0.0 (Europe)
MedGen
UMLS
C0008479
Testes
30 disponíveis
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades